pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4677 |
Genomic Coordinates | chr1: 243346176 - 243346255 |
Description | Homo sapiens miR-4677 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4677-3p | ||||||||||||
Sequence | 50| UCUGUGAGACCAAAGAACUACU |71 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Illumina | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SUMO1 | ||||||||||||||||||||
Synonyms | DAP1, GMP1, OFC10, PIC1, SENP2, SMT3, SMT3C, SMT3H3, UBL1 | ||||||||||||||||||||
Description | small ubiquitin-like modifier 1 | ||||||||||||||||||||
Transcript | NM_001005782 | ||||||||||||||||||||
Other Transcripts | NM_001005781 , NM_003352 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SUMO1 | |||||||||||||||||||||
3'UTR of SUMO1 (miRNA target sites are highlighted) |
>SUMO1|NM_001005782|3'UTR 1 ATATTCTTTTTATTTTTTTTCTTTTCCCTCAATCCTTTTTTATTTTTAAAAATAGTTCTTTTGTAATGTGGTGTTCAAAA 81 CGGAATTGAAAACTGGCACCCCATCTCTTTGAAACATCTGGTAATTTGAATTCTAGTGCTCATTATTCATTATTGTTTGT 161 TTTCATTGTGCTGATTTTTGGTGATCAAGCCTCAGTCCCCTTCATATTACCCTCTCCTTTTTAAAAATTACGTGTGCACA 241 GAGAGGTCACCTTTTTCAGGACATTGCATTTTCAGGCTTGTGGTGATAAATAAGATCGACCAATGCAAGTGTTCATAATG 321 ACTTTCCAATTGGCCCTGATGTTCTAGCATGTGATTACTTCACTCCTGGACTGTGACTTTCAGTGGGAGATGGAAGTTTT 401 TCAGAGAACTGAACTGTGGAAAAATGACCTTTCCTTAACTTGAAGCTACTTTTAAAATTTGAGGGTCTGGACCAAAAGAA 481 GAGGAATATCAGGTTGAAGTCAAGATGACAGATAAGGTGAGAGTAATGACTAACTCCAAAGATGGCTTCACTGAAGAAAA 561 GGCATTTTAAGATTTTTTAAAAATCTTGTCAGAAGATCCCAGAAAAGTTCTAATTTTCATTAGCAATTAATAAAGCTATA 641 CATGCAGAAATGAATACAACAGAACACTGCTCTTTTTGATTTTATTTGTACTTTTTGGCCTGGGATATGGGTTTTAAATG 721 GACATTGTCTGTACCAGCTTCATTAAAATAAACAATATTTGTAAAAATCATACTAATGCTTATTTTATTTTAATTGTATA 801 GAAAGAAAAAAATGCCTAAAATAAGGTTTTCTTGCATAAATACTGGAAATTGCACATGGTACAAATTTTTTCTTCATTAC 881 TGTACAGTGATGATGTTAATGACTTTGAAGCACTGAAAGTTACTGAAGTGCCTTCTGAATCAAGGATTTAATTAAGGCCA 961 CAATACCTTTTTAATACTCAGTGTTCTGTTTTTTTAAAAACTTGATATTCCTGTATGGTGCATATATGATACAGTTACCT 1041 AATCATGTTGAATAAATGGGCATGCCAAAAATT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000296257.5 | 3UTR | ACAUUUCCAUAUACCUCAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
61 hsa-miR-4677-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT277530 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT296646 | RPS21 | ribosomal protein S21 | ![]() |
![]() |
2 | 4 | ||||||
MIRT306961 | THRB | thyroid hormone receptor beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT439091 | MYC | MYC proto-oncogene, bHLH transcription factor | 0 | 1 | ||||||||
MIRT443953 | LRIT3 | leucine rich repeat, Ig-like and transmembrane domains 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445487 | KLF12 | Kruppel like factor 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446637 | SDC3 | syndecan 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448594 | PCP4L1 | Purkinje cell protein 4 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449822 | FNBP1 | formin binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT450422 | BCL2L14 | BCL2 like 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454907 | SEPT8 | septin 8 | ![]() |
![]() |
2 | 17 | ||||||
MIRT466442 | TFAM | transcription factor A, mitochondrial | ![]() |
![]() |
2 | 6 | ||||||
MIRT474198 | LEPRE1 | prolyl 3-hydroxylase 1 | ![]() |
1 | 1 | |||||||
MIRT474486 | KLHDC8B | kelch domain containing 8B | ![]() |
![]() |
2 | 2 | ||||||
MIRT474900 | KCTD21 | potassium channel tetramerization domain containing 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477670 | EFHD2 | EF-hand domain family member D2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483912 | GNB1L | G protein subunit beta 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT484163 | FAM71B | family with sequence similarity 71 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT487565 | LOXL2 | lysyl oxidase like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489678 | CYP1A1 | cytochrome P450 family 1 subfamily A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491482 | APC2 | APC2, WNT signaling pathway regulator | ![]() |
![]() |
2 | 6 | ||||||
MIRT492745 | PER1 | period circadian clock 1 | ![]() |
![]() |
2 | 10 | ||||||
MIRT499212 | CHRDL1 | chordin like 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT501197 | SUMO1 | small ubiquitin-like modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT522622 | MAP7D1 | MAP7 domain containing 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT523971 | DVL3 | dishevelled segment polarity protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541017 | WIPI2 | WD repeat domain, phosphoinositide interacting 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554741 | RHOC | ras homolog family member C | ![]() |
![]() |
2 | 2 | ||||||
MIRT558910 | CBX5 | chromobox 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561466 | TCEB3 | elongin A | ![]() |
![]() |
2 | 2 | ||||||
MIRT564039 | BIRC5 | baculoviral IAP repeat containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564508 | DUSP3 | dual specificity phosphatase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566854 | LRRC58 | leucine rich repeat containing 58 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574110 | SPINT2 | serine peptidase inhibitor, Kunitz type 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611056 | DAB2 | DAB2, clathrin adaptor protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT615578 | NCS1 | neuronal calcium sensor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT615742 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626785 | IL18RAP | interleukin 18 receptor accessory protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT627338 | TTLL7 | tubulin tyrosine ligase like 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT629039 | KLLN | killin, p53-regulated DNA replication inhibitor | ![]() |
![]() |
2 | 2 | ||||||
MIRT637643 | RASGRP1 | RAS guanyl releasing protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641769 | ZNF207 | zinc finger protein 207 | ![]() |
![]() |
2 | 2 | ||||||
MIRT645719 | PTPRF | protein tyrosine phosphatase, receptor type F | ![]() |
![]() |
2 | 2 | ||||||
MIRT652155 | TRIM71 | tripartite motif containing 71 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659216 | CXXC5 | CXXC finger protein 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661995 | EFTUD2 | elongation factor Tu GTP binding domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662711 | C10orf111 | chromosome 10 open reading frame 111 | ![]() |
![]() |
2 | 4 | ||||||
MIRT663216 | ZNF277 | zinc finger protein 277 | ![]() |
![]() |
2 | 2 | ||||||
MIRT668715 | DIP2C | disco interacting protein 2 homolog C | ![]() |
![]() |
2 | 2 | ||||||
MIRT675132 | FSD2 | fibronectin type III and SPRY domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686180 | ZNHIT6 | zinc finger HIT-type containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695993 | SNX19 | sorting nexin 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702346 | KLHL7 | kelch like family member 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702702 | IPO9 | importin 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708232 | PPP1R26 | protein phosphatase 1 regulatory subunit 26 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713311 | SNRNP25 | small nuclear ribonucleoprotein U11/U12 subunit 25 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713528 | PAFAH2 | platelet activating factor acetylhydrolase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT714651 | FSTL1 | follistatin like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715549 | FPGS | folylpolyglutamate synthase | ![]() |
![]() |
2 | 2 | ||||||
MIRT724289 | KCNMB1 | potassium calcium-activated channel subfamily M regulatory beta subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724433 | TFCP2L1 | transcription factor CP2 like 1 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|